UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report: November 3, 2011
(Date of earliest event reported)
TENET HEALTHCARE CORPORATION
(Exact name of Registrant as specified in its charter)
| Nevada | 1-7293 | 95-2557091 | ||
| (State of Incorporation) | (Commission File Number) | (IRS Employer Identification Number) |
1445 Ross Avenue, Suite 1400
Dallas, Texas 75202
(Address of principal executive offices, including zip code)
(469) 893-2200
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.07 Submission of Matters to a Vote of Security Holders.
(a) The 2011 annual meeting of shareholders of Tenet Healthcare Corporation was held on November 3, 2011.
(b) The shareholders (1) elected all of the board’s nominees for director, (2) approved an advisory resolution on the compensation paid to the company’s named executive officers, (3) indicated their preference that future advisory votes on executive compensation be held annually, and (4) ratified the selection of Deloitte & Touche LLP as the company’s independent registered public accountants for the year ending December 31, 2011.
The final results of voting on each of the matters submitted to a vote are as follows:
1. Election of directors:
| FOR | AGAINST | ABSTAIN | BROKER NON-VOTES | |||||||||||||
John Ellis “Jeb” Bush | 272,644,691 | 101,937,787 | 1,143,911 | 47,148,731 | ||||||||||||
Trevor Fetter | 318,677,997 | 56,976,353 | 72,039 | 47,148,731 | ||||||||||||
Brenda J. Gaines | 302,048,388 | 72,534,943 | 1,143,058 | 47,148,731 | ||||||||||||
Karen M. Garrison | 273,023,919 | 101,552,463 | 1,150,007 | 47,148,731 | ||||||||||||
Edward A. Kangas | 277,761,550 | 97,787,981 | 176,858 | 47,148,731 | ||||||||||||
J. Robert Kerrey | 272,775,886 | 101,766,006 | 1,184,497 | 47,148,731 | ||||||||||||
Floyd D. Loop, M.D. | 272,569,686 | 101,996,230 | 1,160,473 | 47,148,731 | ||||||||||||
Richard R. Pettingill | 316,341,476 | 58,222,458 | 1,162,455 | 47,148,731 | ||||||||||||
Ronald A. Rittenmeyer | 316,716,390 | 57,852,958 | 1,157,041 | 47,148,731 | ||||||||||||
James A. Unruh | 272,402,123 | 102,180,537 | 1,143,729 | 47,148,731 | ||||||||||||
2. Approval of an advisory resolution on the compensation paid to the company’s named executive officers:
FOR | AGAINST | ABSTAIN | BROKER NON-VOTES | |||
| 320,317,032 | 53,062,153 | 2,347,204 | 47,148,731 |
2
3. Approval, on an advisory basis, of the option of every “1 Year,” “2 Years,” or “3 Years” for future advisory votes on executive compensation:
1 YEAR | 2 YEARS | 3 YEARS | ABSTAIN | BROKER NON- | ||||
| 327,108,888 | 748,570 | 44,212,107 | 3,656,824 | 47,148,731 |
4. Ratification of the selection of Deloitte & Touche LLP as the company’s independent registered public accountants for the year ending December 31, 2011:
FOR | AGAINST | ABSTAIN | BROKER NON- | |||
| 421,406,996 | 1,294,912 | 173,212 | — |
(d) Based on the results of the advisory vote on the frequency of future advisory votes on executive compensation, and consistent with the recommendation of the board, the board adopted a resolution providing that an advisory vote on the compensation of the company’s named executive officers would be held annually until the next advisory vote on the frequency of future advisory votes on executive compensation.
3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| TENET HEALTHCARE CORPORATION | ||
| By: | /s/ Gary Ruff | |
Gary Ruff Senior Vice President and General Counsel | ||
Date: November 4, 2011
4